Genting Berhad:戦略・SWOT・企業財務分析

◆英語タイトル:Genting Berhad - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015758
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:建設・不動産
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Genting Berhad – Strategy, SWOT and Corporate Finance Report
Summary

Genting Berhad – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Genting Berhad (Genting or “the company”) is an investment holding and management company of Genting Group, which is engaged in power generation, oil palm plantations, property development, cruise, biotechnology, and oil and gas. The company primarily operates in the US, Asia, and the UK. It is headquartered in Kuala Lumpur, Malaysia and employed more than 60,000 people as on December 31, 2014.

Scope

- Detailed information on Genting Berhad required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Genting Berhad in the form of a SWOT analysis
- An in-depth view of the business model of Genting Berhad including a breakdown and examination of key business segments
- Intelligence on Genting Berhad’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Genting Berhad, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Genting Berhad and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Genting Berhad as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Genting Berhad’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Genting Berhad: Company Overview
Genting Berhad: Overview and Key Facts
Genting Berhad: Overview
Genting Berhad: Key Facts
Genting Berhad: Key Employees
Genting Berhad: Key Employee Biographies
Genting Berhad: Major Products and Services
Genting Berhad: Company History
Genting Berhad: Management Statement
Genting Berhad: Locations and Subsidiaries
Genting Berhad: Key Competitors
Genting Berhad: Company Analysis
Genting Berhad: Business Description
Genting Berhad: SWOT Analysis
Genting Berhad: SWOT Overview
Genting Berhad: Strengths
Genting Berhad: Weaknesses
Genting Berhad: Opportunities
Genting Berhad: Threats
Genting Berhad: Corporate Financial Deals Activity
Genting Berhad: Financial Deals Overview
Genting Berhad: Targets and Partners
Genting Berhad: Top Deals 2013 – 2017YTD*
Genting Berhad: Mergers and Acquisitions
Genting Berhad: Corporate Venturing
Genting Berhad: Divestments
Genting Berhad: Recent Developments
Genting Berhad: News and Events Summary
Genting Berhad: Corporate Governance
Genting Berhad: Financial Performance
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Genting Berhad: Key Facts
Table 2: Genting Berhad: Key Employees
Table 3: Genting Berhad: Locations and Subsidiaries
Table 4: Genting Berhad: Key Competitors
Table 5: Genting Berhad: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Genting Berhad: M&A Average Deal Size - Value (US$m)
Table 7: Genting Berhad: Targets and Partners
Table 8: Genting Berhad: Top Deals 2013 - 2017YTD*
Table 9: Genting Berhad: M&A Volume and Value Trend (2013 - YTD*2017)
Table 10: Genting Berhad: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 11: Genting Berhad: Corporate Venturing by Geography (2013 - YTD*2017)
Table 12: Genting Berhad: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 13: Genting Berhad: News and Events Summary
Table 14: Genting Berhad: Corporate Governance
Table 15: Genting Berhad: Financial Performance

★海外企業調査レポート[Genting Berhad:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abbott Point of Care Inc:企業の製品パイプライン分析2018
    Summary Abbott Point of Care Inc (Abbott Point), a subsidiary of Abbott Laboratories, is a medical device company that offers diagnostic products. The company manufactures, develops, and distributes medical diagnostic and data management products for in-vitro diagnostic and healthcare markets. Its p …
  • Emirates NBD Bank PJSC:企業の戦略・SWOT・財務情報
    Emirates NBD Bank PJSC - Strategy, SWOT and Corporate Finance Report Summary Emirates NBD Bank PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Aspial Corporation Ltd (A30):企業の財務・戦略的SWOT分析
    Aspial Corporation Ltd (A30) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Advaxis Inc (ADXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Advaxis Inc (Advaxis) is a biotechnology company that focuses on the discovery, development and commercialization of multiple cancer immunotherapies. The company develops immunotherapies based on its proprietary Lm Technology that uses bioengineered live attenuated Listeria monocytogenes (Lm …
  • bioLytical Laboratories Inc:企業の製品パイプライン分析
    Summary bioLytical Laboratories Inc (bioLytical) operates as a medical device company that develops and manufactures HIV diagnostic products. The company provides products such as insti HIV-1 and HIV-2 antibody test and insti HIV-1 and HIV-2 test controls. Its product line offers test result that tr …
  • Southern Company Gas:企業の戦略的SWOT分析
    Southern Company Gas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • JAND, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary JAND, Inc. (JIN), doing business a warby parker, is a manufacturing company. The company engages in operations of optical manufacturer. JIN product portfolio consists of eyeglasses, sunglasses, and gift cards. The company also manufactures and sale of eyewear for men and women. It also offer …
  • SK Biopharmaceuticals Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a researcher and developer of drugs. The company develops and markets drugs for the treatment of central nervous system. It provides plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL-A4R …
  • Websol Energy System Ltd (WEBELSOLAR):企業の財務・戦略的SWOT分析
    Summary Websol Energy System Ltd (Websol) is an alternate energy company that offers manufacturing of photovoltaic crystalline solar cells and the related modules. The company offers products such as pv solar cell and pv solar module. Its pv solar cell includes multi crystalline 4bb pv solar cell, m …
  • Tetra Technologies, Inc.:企業の戦略・SWOT・財務分析
    Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Manitou Bf Sa:企業の戦略・SWOT・財務分析
    Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report Summary Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Zenotech Laboratories Ltd (532039):製薬・医療:M&Aディール及び事業提携情報
    Summary Zenotech Laboratories Ltd (Zenotech) manufactures and markets generic biopharmaceuticals products. It classifies its products into two categories, namely, generic biopharmaceuticals and new biological. The company’s Generic biopharmaceuticals is further sub-divided into generic biological an …
  • Innovative Solutions and Support, Inc.:企業の戦略・SWOT・財務情報
    Innovative Solutions and Support, Inc. - Strategy, SWOT and Corporate Finance Report Summary Innovative Solutions and Support, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Natural Resource Partners L.P.:企業のM&A・事業提携・投資動向
    Natural Resource Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Natural Resource Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Herantis Pharma Plc (HRTIS):企業の財務・戦略的SWOT分析
    Summary Herantis Pharma Plc (Herantis Pharma) operates as a drug development company that offers regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. …
  • Applied Industrial Technologies, Inc.:企業の戦略・SWOT・財務情報
    Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • University of Texas Health Science Center at San Antonio-医療機器分野:企業M&A・提携分析
    Summary University of Texas Health Science Center at San Antonio (UTHSCSA), a subsidiary of University of Texas System is an educational university that offers undergraduate, graduate, and research programs to physicians, biomedical scientists, aging and longevity, cancer, cardiovascular, diabetes, …
  • Arab African International Bank:企業の戦略・SWOT・財務情報
    Arab African International Bank - Strategy, SWOT and Corporate Finance Report Summary Arab African International Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Esperion Therapeutics Inc (ESPR):製薬・医療:M&Aディール及び事業提携情報
    Summary Esperion Therapeutics Inc (Esperion), a subsidiary of Pfizer Inc is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprote …
  • Genome British Columbia:医療機器:M&Aディール及び事業提携情報
    Summary Genome British Columbia (Genome BC) is a non-profit medical research organization that conducts genomics and proteomics research, and offers science and technology solutions. The organization provides prognostic, new diagnostic, and therapeutic tools for use in personalized medicine. It also …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆